e8vk
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report: April 19, 2010
(Date of earliest event reported)
IDEX CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
1-10235
|
|
36-3555336 |
(State of
|
|
(Commission File Number)
|
|
(IRS Employer |
Incorporation)
|
|
|
|
Identification No.) |
630 Dundee Road
Northbrook, Illinois 60062
(Address of principal executive offices, including zip code)
(847) 498-7070
(Registrants telephone number, including area code)
Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Item 7.01 Regulation FD Disclosure.
Q1 2010 Presentation Slides and Conference Call Transcript
Presentation slides and a transcript of a conference call discussing IDEX Corporations quarterly
operating results are attached to this Current Report on Form 8-K as Exhibits 99.1 and 99.2 and are
incorporated herein by reference.
The Securities and Exchange Commission encourages companies to disclose forward-looking information
so that investors can better understand the future prospects of a company and make informed
investment decisions. This Current Report and exhibit may contain these types of statements, which
are forward-looking statements within the meaning of the Private Securities Litigation Reform Act
of 1995, and which involve risks, uncertainties and reflect IDEXs judgment as of the date of this
Current Report.
Forward-looking statements may relate to, among other things, operating results and are indicated
by words or phrases such as expects, should, will, and similar words or phrases. These
statements are subject to inherent uncertainties and risks that could cause actual results to
differ materially from those anticipated at the date of this Current Report. The risks and
uncertainties include, but are not limited to IDEXs ability to integrate and operate acquired
businesses on a profitable basis and other risks and uncertainties identified under the heading
Risk Factors included in Item 1A of IDEXs Annual Report on Form 10-K for the year ended December
31, 2009 and information contained in subsequent periodic reports filed by IDEX with the Securities
and Exchange Commission. Investors are cautioned not to rely unduly on forward-looking statements
when evaluating the information presented within.
The information in this Current Report furnished pursuant to Items 7.01 and 9.01 shall not be
deemed filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended,
or otherwise subject to the liabilities of that Section. This information shall not be incorporated
by reference into any registration statement pursuant to the Securities Act of 1933, as amended.
The furnishing of the information in this Current Report in not intended to, and does not,
constitute a representation that such furnishing is required by Regulation FD or that the
information this Current Report contains is material investor information that is not otherwise
publicly available.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
99.1 |
|
Presentation slides of IDEX Corporations quarterly operating results |
|
|
99.2 |
|
Transcript of IDEX Corporations earnings conference call on April 19, 2010 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
IDEX CORPORATION
|
|
|
By: |
/s/ Dominic A. Romeo
|
|
|
|
Dominic A. Romeo |
|
|
|
Vice President and Chief Financial Officer |
|
|
April 21, 2010
Exhibit Index
|
|
|
Exhibit |
|
|
Number |
|
Description |
|
|
|
99.1
|
|
Presentation slides of IDEX Corporations quarterly operating results |
|
|
|
99.2
|
|
Transcript of IDEX Corporations earnings conference call on April 19, 2010 |
exv99w1
EXHIBIT 99.1
IDEX Corporation
First Quarter 2010
Earnings Release
April 19, 2010
|
Agenda
Q1 2010 Summary
Q1 2010 Segment Performance
Fluid & Metering
Health & Science
Dispensing Equipment
Fire & Safety
2010 Guidance Update
Q&A
1
|
Replay Information
Dial toll-free: 800.642.1687
International: 706.645.9291
Conference ID: #62850085
Log on to: www.idexcorp.com
2
|
Cautionary Statement
Under the Private Securities
Litigation Reform Act
This presentation and discussion will include
forward-looking statements. Our actual performance
may differ materially from that indicated or suggested by
any such statements. There are a number of factors that
could cause those differences, including those presented
in our most recent annual report and other company
filings with the SEC.
3
|
Q1 2010 Financial Performance
*Q1 '10 adjusted for $1.9M of restructuring expense ($2.3M in Q1 '09)
Return to growth, solid profitability
4
Q1 '10 Q1 '09 Var
Orders $370 $336 10%
Sales $356 $327 9%
Adj. Op Margin* 16.8% 12.7% 410 bp
Adj. EBITDA* $74 $55 36%
Adj. EPS* $.46 $.30 55%
FCF $20 $13 50%
|
Fluid & Metering
*Op Margin excludes restructuring expense in both Q1'10 and Q1'09
Q1 2010 Highlights
14% organic orders growth, 7% organic sales growth, 18.8% operating margins
Strong demand for water/wastewater services and project spend
2010 Outlook
Energy & Water will continue to benefit from strong global markets
Modest recovery in Chemical and general industrial markets
Q1 '10 Q1 '09 Change
Orders $179.2 $153.8 17%
Sales
Organic
Currency $172.9
$157.0
10%
7%
3%
Operating Margin* 18.8% 14.7% 410bp
Strong global growth in energy and water, recovery in other markets
5
|
Health & Science
*Op Margin excludes restructuring expense in both Q1'10 and Q1'09
Q1 2010 Highlights
27% organic orders growth, 17% organic sales growth, 21.8% operating margins
Strong growth across all HST products
Acquired Seals, LTD; Seals is a UK based firm producing high-performance
polymer seals for the life sciences marketplace, among others
2010 Outlook
Core analytical instrumentation markets continue to grow
Industrial markets supported by broader economic stabilization
Q1 '10 Q1 '09 Change
Orders $96.5 $75.6 28%
Sales
Organic
Currency
$87.5
$74.2
18%
17%
1%
Operating Margin* 21.8% 14.2% 760bp
Core markets improving, strong performance in the segment
6
|
Acquisition of Seals Ltd. (April 2010)
Headquartered in Blackburn, England, with annual revenues of
approximately £21 million, Seals is a leading provider of high
performance seals and advanced sealing solutions
Seals focuses on critical sealing applications in the most
severe duty conditions
Seals' products enable chromatography and other life science
tools and are widely used in industrial applications where
temperature and chemical resistance are paramount
Growth drivers:
Demand for higher levels of purity in food and pharmaceutical
Micro-fluids that are aggressive and therefore demand new sealing
solutions
Custom solutions for new instrumentation
Extends IDEX's capabilities in the life science, pharmaceutical
and core industrial markets
Adds a significant technology to IDEX Health and Science
Integrated Solutions Group (more of the fluid path)
7
|
Dispensing Equipment
Q1 2010 Highlights
20.1% operating margins
2010 Outlook
Overall order activity in North American retail channel and European markets
remain slow
Cost reductions will result in reasonable profitability and strong cash flow
Q1 '10 Q1 '09 Change
Orders $35.4 $48.8 (27)%
Sales
- -Organic
Currency
$33.6 $32.9 2%
(3)%
5%
Operating Margin* 20.1% 12.1% 800bp
Continued market softness in North America and Europe; improved profitability
*Op Margin excludes restructuring expense in both Q1'10 and Q1'09
8
|
Fire & Safety / Diversified Products
Q1 2010 Highlights
21.2% operating margins
2010 Outlook
Strong global activity in rescue tools
N.A. fire suppression down due to decline in municipal spend
Band clamping markets improving
Q1 '10 Q1 '09 Change
Orders $61.6 $62.4 (1)%
Sales
- -Organic
Currency $63.4
$65.0
(2)%
(5)%
3%
Operating Margin* 21.2% 20.9% 30bp
Global growth in rescue tools; band clamping end markets improving
*Op Margin excludes restructuring expense in both Q1'10 and Q1'09
9
|
2010 Guidance Summary
Q2 2010
EPS estimate range: $0.45 - $0.47
Organic revenue growth of 5-6%
Positive Fx impact of ~1% to sales (at current rates)
FY 2010
EPS estimate range: $1.75 - $1.80
Organic revenue growth in mid-single digit range
Operating margins of approximately 16.5%
Positive Fx impact of less than 1% to sales (at current rates)
Tax rate = 33%
Other modeling items
Cap Ex $28-30M
Free Cash Flow exceeds net income
EPS estimate excludes potential restructuring and acquisition charges
10
|
exv99w2
EXHIBIT 99.2
MANAGEMENT DISCUSSION SECTION
Operator: Good day, and welcome, everyone, to the IDEX First Quarter 2010 Earnings Results
Conference Call. This call is being recorded. At this time, for opening remarks and introductions,
I would like to turn the call over to Mr. Heath Mitts, Vice President of Corporate Finance. Please
go ahead, sir.
Heath A. Mitts, Vice President, Corporate Finance
Good morning, and thank you for joining us for our discussion of the IDEX first quarter 2010
financial results. This morning we issued a press release outlining our companys financial and
operating performance for the three months period ending March 31, 2010. The press release, along
with the presentation slides to be used during todays webcast, can be accessed on our company
website at www.idexcorp.com.
Joining me today from IDEX management are Larry Kingsley, Chairman and CEO; and Dom Romeo, Vice
President and CFO.
The format for our call today is as follows. We will begin with an update on our overall
performance for the quarter and then provide an provide detail on our four business segments. We
will then ramp up with the outlook for 2010. Following our prepared remarks well then open the
call for your questions. If you should need to exit the call for any reason, you may access a
complete replay beginning approximately two hours after the call concludes by dialing the toll-free
number 800-642-1687 and entering conference I.D. 62850085, or simply log on to our companys
homepage for the webcast replay.
As we being, a brief reminder, this call may contain certain forward-looking statements that are
subject to the safe harbor language in todays press release and in IDEXs filings with the
Securities and Exchange Commission.
With that, Ill now turn this call over to our Chairman and CEO, Larry Kingsley. Larry?
Larry D. Kingsley, Chairman, President and Chief Executive Officer
Thanks, Heath, and good morning, everyone. Before we discuss the first quarter results, Ill run
through some general comments as to what were seeing out there. As we ended 09, most of our end
markets had stabilized and some were beginning to grow again. Throughout the first quarter this
trend continued with order rates in many of our Fluid & Metering and Heath & Science markets
growing at a better pace than our original expectations.
Operationally, we are positioned very well to respond, to take advantage of the demand surge and to
take share with very competitive lead-times. And Ill dive into detail later in the presentation,
but briefly in terms of where the upside is coming from, Asia, the Middle East; most of the
developing markets look just great for the full year. In Q1 we saw orders and sales growth of over
30% in Asia. And the global infrastructure investment is now translating to orders. The Water
business is doing well with major new water monitoring programs and capital improvement projects
underway. The federal governments globally are allocating to spend on new programs particularly in
Europe.
Our Health & Science segment grew very nicely in the quarter across all businesses. Market growth
especially international again as been solid and we continue to take share on new instrumentation
platforms. Our operating metrics across the company reflect strong margin performance and we have
line of sight to very solid operational execution throughout the year.
And with regard to capital deployment on April 6, we announced a 25% increase to our dividend, and
as you know, we just announced last week that we completed the acquisition of Seals, Limited, a new
unit in the Health & Science segment. Seals allows us to move into an attractive adjacent product
segment within our core HST portfolio. And we continue to move along in the late-stage of the
diligence on additional acquisition targets and thats in both the Fluid & Metering and of the
Health & Science segment.
So Im going to turn over to slide four, the financial performance overview slide. For the quarter,
orders were up 10% and thats 8% organically. Sales were up 9% and thats up six organically. First
quarter adjusted operating margin of 16.8% was up 410 basis points from the comparable quarter last
year. The stronger profitability is the result of leverage on the organic growth. All of our
segments experienced year-over-year margin expansion. Q1 EPS at $0.46 was up 55% versus the
comparable EPS last year. Free cash of $21 million was up 50% from the first quarter of 09. So,
all-in-all, a very good quarter and a really good start to the year.
In Fluid & Metering now to jump into the segments, orders were up 17% in the quarter and thats 14%
organically. Sales increased 10%, thats up 7% organically. Adjusted operating margin of 18.8% was
up 410 basis points here in the segment as well for the quarter. We saw year-over-year improvement
in nearly all of the markets during the first quarter and were seeing strong global demand for the
newer products.
Within our energy markets top line growth is materializing as expected. Our investments in the BRIC
countries as well as in the Middle East are doing quite well. Theyre paying off while the domestic
markets are still a little slower to return to growth. In most all regions however our mid and
upstream fuel management projects, as well as the LPG applications are trending quite well.
Without our Water business, U.S. municipal markets continue to struggle with near-term funding, but
we do remain very bullish that we are very well positioned for these projects as they materialize
and were going to capitalize on those opportunities.
In Europe, the highlight for the quarter was in the U.K. Our water strategy has really come
together pretty nicely. We won a multi-year program associated with the asset management plan in
the U.K. water industry. And this first program is an example of the type of water project that
weve been talking about, the activity that we now have underway. The other FMT served markets are
also improving. Were seeing better performance than we anticipated and talked about last quarter.
And were seeing that both for distribution to the end markets, were also seeing that though in
the OEM direct buying patterns.
So in summary for the Fluid & Metering segment, the energy and water markets are growing as we had
expected and we are definitely optimistic about what were seeing out of the rest of the segment.
Our updated thinking for the year is that within the segment chemical and industrial will grow in
2010 and therefore the FMT segment total will grow in the high single-digit range organically.
In our Health & Science segment, if you flip over to the next slide total orders were up 28% for
the quarter, thats up 27% organically. Sales were up 18% in total, thats 17 organically.
Operating margin of 21.8% was up 760 basis points compared to the prior year. Its obviously driven
by volume, but also cost reductions and prior year acquisition-related costs. Again, all the
businesses experienced strong margin expansion.
As expected we, saw a return to year-over-year market growth in the life sciences and the end
market growth is pretty broad based, but definitely most pronounced in the international markets
and particularly in India and China.
Our expanding product range here though and the solutions capabilities continue to drive growth as
well and were seeing very nice instrument content gain, particularly in the new analytical and
diagnostic platforms. Within our more industrialized health and science markets, weve also seen
good strong growth. General market recovery varies by geography, but new product and take share
strategies are clearly paying off. So obviously 17% organic sales growth in the first quarter
exceeded our short-term expectations
In the quarter, we did receive the benefit of increased OEM purchases in advance of their platform
rollouts. But all said, were definitely winning winning big and we anticipate excellent growth
to continue for the full year. For the year, we expect HST organic revenue growth to be high
single-digit for the segment.
Im going to take a few minutes here just talk a bit about the Seals acquisition that we announced
last Thursday. As weve discussed, our strategic focus for capital deployment in the segment is
within the analytical instrumentation and life science markets. And with Seals, what we have now is
the combination of breakthrough technologies, some additional material science and some great new
products that immediately contribute to the HST revenue stream.
Beyond their core strength in the life science applications, we intend to develop the line to serve
other HST and FMT markets as well. And Seals supplies some of the same customers that we have
historically served. Theres a growing need for higher levels of purity in food, as you know weve
talked about, pharmaceutical. We also see some great opportunities in electronics manufacturing.
Basically, multiple opportunities across the portfolio.
Today, about 40% of their current revenue is in life science applications, 20% is in food and
pharma and the remainder is in the other industrial electronics applications. Regionally, about 60%
of their sales are in Europe, about 20% is in U.S. and 20% in the rest of the world. So we welcome
Seals to the IDEX team. Its a great addition, and as I said, we get multiple things out of it.
Im going to turn to Dispensing now. Im on slide eight. Total orders in the quarter were down 27%.
Organically theyre down 30. Sales increased two, but were down 3% organically. Operating margin is
just over 20%, was up significantly compared to the prior year as a result of our restructuring
initiatives, as well as just continued broad-based operational improvement.
Overall, the underlying market conditions continue to be soft in both North America and Europe. We
expect the general environment to remain challenged and order activity within the U.S. retail
channel as well as the European market to be slow for the remainder of the year. And as you know,
weve talked before, the lumpiness in this business is largely driven by program orders. Our teams
persistence though has paid off in the quarter as we were able to book a sizeable DIY, thats a
do-it-yourself replenishment order and thatll benefit the first half of this year.
However, despite the recent order, our year-over-year results for the segment will be unfavorable
still due to a significantly larger similar kind of DIY replenishment order in Q1 of 09. All said,
the impact to the growth rate, to the total company is minimal as the segment is about 9% of sales.
I want to say though, our Dispensing team has done just a great job of managing the business and
the segment is obviously very profitable and itll generate a good deal of cash this year.
So moving on to Fire & Safety. For the quarter, total orders were down 1%, organics were down four,
sales were down two and organics were down five. Operating margin at 21.2% was up 30 basis points
compared to last year primarily due to mix within the segment.
As expected, the global activity versus the domestic market continues to be strong and growing
particularly for rescue equipment, but our band clamping business is performing well. Also, it is
experiencing solid growth year-over-year. Its the fire suppression portion of the segment within
North America that is negatively impacted by muni budget constraints.
And moving forward, emerging country markets will be by far the best growth opportunities and for
rescue in particular. The China rescue market is expected to grow significantly over the next
several months and years. And we will leverage our in-country capabilities, as well as our global
portfolio, to address those expanding needs.
BAND-IT is enjoying the benefit in the segment too of just a good, general rebound in the economy,
as well as just solid sales execution against strong broad-based, but also very good new product
performance.
So in total for the segment, we still expect organic growth to be flat to down slightly for the
full year with international growth to be offset by domestic municipal spend issues. BAND-IT and
rescue will be up and fire will be down, so profitability and cash flow obviously will continue to
be outstanding.
Im going to move on to guidance. Im on slide 10. We expect Q2 EPS to be in the 0.45 to $0.47
range. Q2 organic revenue growth will be up five to 6%. FX will have a positive impact of about a
point.
For the full year, we have raised our guidance. Our EPS range is now $1.75 to $1.80, thats again
driven by the organic revenue growth assumptions that are mid-single digit range, and given the
improved first half outlook, we now expect FMT and HST to achieve closer to high single-digit
organic sales growth. And as I said, we expect Fire & Safety to be flat to down slightly.
For Dispensing, we continue to expect organic sales to be down slightly for the full year. Thats
inclusive of the large first half order. Operating margin for the company will be approximately
16.5% on a full year basis. Our flow through on that incremental organic revenue will be about 45%.
For the year, we expect FX to also have an impact of about a point, positively. These estimates
obviously do not include any acquisition-related impact from the Seals transaction.
And as far as other modeling items, the 2010 tax rate is anticipated to be 33%. Full year CapEx
will be between 28 to $30 million. Well obviously continue to convert cash very well, well in
excess of net income. And our also note our projections here exclude any estimate for any
additional restructuring costs for the remainder of the year.
So with that, were going to open the line to questions. Operator?
QUESTION AND ANSWER SECTION
Operator: Thank you. [Operator Instructions]. Our first question comes from Jim Lucas with Janney
Montgomery. Please state your question.
<Q Jim Lucas>: All right. Thanks. Good morning, guys.
<A Larry Kingsley>: Good morning, Jim.
<Q Jim Lucas>: First question on more of a housekeeping, with regards to the corporate
expense line, we had saw a big jump in the fourth quarter and then seems to have leveled off here
in the first quarter. Is this essentially the run rate we can expect going forward?
<A Larry Kingsley>: Yeah. You can use that as an assumption, Jim.
<Q Jim Lucas>: Okay. And with regards to Health & Science, I mean, clearly very strong
showing across the board. Was wondering, you know you made the comment about OEM orders going
forward, any color you can provide with what youre seeing from an impact with regards to stimulus
in the and the impact on the NIH?
And also with regards to mix, this is one of the better margin showing weve seen in quite some
time, was this really all the stars aligning? Or is this a type of margins we can expect to see
going forward?
<A Larry Kingsley>: Yeah. Well, lets start with the top line, Jim. Obviously, organic
orders performance of 27% is huge. There are a number of new platform I want to call them
planning for positive sales blanket orders that are built within that. We bridge this a number of
different ways to first understand that impact. So if you look at first quarter at 27% versus if
you factored out all of those new platform ramp up kinds of commitments, you still bridge to
something like 17% organic orders. And obviously that in truth was the sales number.
As far as how much of the total order performance in the quarter was related to NIH or stimulus
kind of funding, we actually dont think thats a huge number. We think theres a couple of points
thats tied into that. But most of our customers are seeing pretty nice international gains as
well. So and as I said in the prepared remarks, as we can discern where the sell-through numbers
are on a geographic basis, international performance is better than U.S. and U.S. obviously is
where youd see that NIH impact.
As far as the margin performance in the quarter, the team is just doing a great job. We got a lot
of costs down. Were seeing some benefits there. We lapped some of that. Later in the year you
wont see the same kind of year-over-year margin improvement. But were certainly at this point to
a very, very competitive cost position. And were going to continue to see reasonable organic
performance, I think fantastic margins across the business.
So its not really the stars aligning in terms of best mix. Mix will bounce up and down slightly in
the segment. It always does. But its never been one that hugely varies. And I think that what
youre seeing now is really good leverage frankly, obviously on the cost actions that were taking
and obviously very good flow through on that organic revenue.
<Q Jim Lucas>: Okay. Very helpful. Thanks. And finally, with regards to the acquisition
pipeline, could you talk about what youre seeing from a valuation standpoint out there? And the
types of deals that youre looking at today, are they more comparable to the Seals where were
seeing bunts and singles or is there potentially something bigger in the pipeline?
<A Larry Kingsley>: Its a little of both, Jim, in terms of size. Weve got quite a few
things going on right now. And they are in the seals size range to 2X the seals size range right
now, some that are probably less probable that are a little bit larger. There are enough of them.
But I think we feel very good about capital deployment for the full year and are all going to be
strategically right down the middle, really, really good adds for us.
As far as what we are seeing out there in terms of valuations, I would tell you that were
comfortable that of the acquisitions that were in process with, theyre going to be really good
returns to the company. As you know, we
prefer proprietary deals versus auctions and I would make that comment specifically to what were
seeing on the proprietary side. And the auction side is a bit of a mixed bag right now. And in some
cases in several cases, weve chosen early to opt out because we dont think the valuations are
warranted.
So anyway, I think its going to be a good year for capital deployment for the company. I think
were going to be very pleased with what we look back at the end of the year and say these were
all solid adds. As you know, we build more technology and growth into all of what we have by way of
acquisitions. Were really pleased with what weve done over the last several years. Youll see
similar things to come here.
<Q Jim Lucas>: Okay. Great. Thank you very much.
<A Larry Kingsley>: Sure.
Operator: Our next question comes from Christopher Glynn with Oppenheimer. Please state your
question.
<Q Christopher Glynn>: Thanks. A little further into the HST orders, I think you called out
some OE stocking, but if we could look at what the lead times in to recognized revenues are with
some of the mix of these things, it just seems a little tough to tie it back to high single-digits
organic growth, what youre seeing here. So maybe if you could help a little bit more on that
front?
<A Larry Kingsley>: I would yeah, Id bridge it in two steps. First, what we talked about
is bridging 27% organic orders to 17% organic orders given a fairly broad based really robust
representation of that 17% organic line. The difference there that 10 points has not so much the
classical stocking element to it, but it has the ramp-up associated with some new platforms that
are coming out pretty strong from our customers. And so while were typically subsystems on those,
the advanced look on all of that looks pretty positive.
When you look at the bridge, if you want to bridge it, between 17 and call it high single digits,
thats just more a view of the world is continuing to understand how robust the economy is. We
feel very good about our execution. And one could argue at this point looking forward that high
single digit for the segment is perhaps a bit pessimistic. I think as we go forward by quarter,
youll continue to hear us talk pretty positively about what were seeing. But so far its been
solid execution. And I think were in a really good position operationally to take advantage of the
surge in demand that we do see as we look forward, more of the same.
<Q Christopher Glynn>: Okay. And then I dont think you mentioned the accretion or impact
of sales if you did, Im sorry, I missed it, but any commentary there?
<A Larry Kingsley>: I did not specific to the acquisition?
<Q Christopher Glynn>: Yes.
<A Larry Kingsley>: No, I didnt and we just dont have that assumption built in one way or
the other for the short term or beyond 2010 at this point.
<Q Christopher Glynn>: Okay. Thank you very much.
<A Larry Kingsley>: Sure.
Operator: Our next question comes from Mike Halloran with Robert W. Baird. Please state your
question.
<Q Michael Halloran>: Good morning. Question on sequential revenue trends through the year,
could you just refresh my memory on what a typical sequential revenue trend for your HST and FMT
divisions look like through a year? And any reason you think that would deviate this year relative
to what that historical trend would look like?
<A Larry Kingsley>: I would Dom will give you what the sequential seasonal pattern
typically looks like for the two segments, Mike. But I dont know that I would compare 2010 to 09
obviously given the nature of 09 for all companies and all businesses. But, Dom, why dont you...?
<A Dominic Romeo>: Sure. I think, Mike, you have to go back to probably 06, 07, 08
timeframe, HST, historically pretty linear by quarter. There have been times in the fourth quarter
where SIAP has gotten a little bit ahead of itself with our customers where youve seen a minor dip
in the fourth quarter. But our assumption is kind of sequential good linearity within quarters for
HST.
And probably where youre going is FMT, which historically Q1 is the lowest quarter and Q2, 3 and 4
tend to be the upticks. So thats a wait and see for us but Im sure thats where youre at in
terms of historic linearity. So well have to wait and see how it plays out. The good news there
though is on orders; even without the blankets were seeing nice Q1 organic quarter or growth as
well.
<Q Michael Halloran>: And I guess the reason I bring it up is you guys commented on the 45%
incremental margins for the full year being still the target. And if you take that normal
sequential build, you get something a little bit above or certainly above what your current
guidance range is. And Im just kind of wondering, from a full year perspective, if theres
something else going on that Im missing?
<A Larry Kingsley>: For FMT, the answer is no, and there is some upside for certain with
respect to the full year operating line.
<Q Michael Halloran>: Okay. Thanks, guys.
<A Larry Kingsley>: Sure, Mike.
Operator: Our next question comes from Charles Brady with BMO Capital.
<Q Thomas Brinkmann>: Good morning. This is actually Tom Brinkmann standing in for Charlie
Brady. Just had a couple of questions for you about some of your end markets, what youre seeing.
How about the chemical and refining end markets domestically? Have you seen any pickup there?
<A Larry Kingsley>: We have, Tom. What were seeing as I mentioned I think in the prepared
remarks, a little bit better order activity and fairly broad based for our Fluid & Metering markets
that were expected to be a bit slower in terms of pickup that were chemical and some of the more
general industrial end segments. Were seeing that as a combination of project activity, but robust
MRO demands too, as its kind of a good blend.
As you know, we started the year with the assumption that what was really going to drive good
growth across FMT was Energy and Water. Weve certainly seen that, feel very good about that
particularly what were seeing happening in Water. But what we had assumed at the beginning of the
year was that there would be a bit of a drag in terms of the chemical and call it industrial
pieces. I would tell you that were feeling incrementally better about that portion of FMT, so
again, well continue to monitor it, look a quarter out again and see where we are at the end of Q2
but right now certainly we dont see the drag in the segment at all.
<Q Thomas Brinkmann>: Okay. Thats good. Also, just wondered if you could sort of talk
about the difference in if the Water end markets doing better, if thats some municipal oriented
activity? And how that compares to your a little bit more downbeat outlook for the Fire Suppression
market with municipal spending?
<A Larry Kingsley>: Yes, well, theres a couple different things going on. First, we
broadly categorize whats going with Water is the very solid execution, whats going with our team,
and its global before its domestic. So what were seeing is water infrastructure projects getting
to the point of monetization internationally before they are here in the U.S. At the same time what
were seeing is that out of the U.S. municipal spend budgets that water is a higher priority than
fire right now. And there is obviously various forms of stimulus most of which in the U.S. have not
made their way to program orders, but certainly looking better.
And when we look at whats going to happen over the next few years, not just the rest of this year
for water, weve got pretty good assurances frankly that the global infrastructure stuff is going
to drive fantastic growth and the U.S. municipal spends will come back in terms of priority ahead
of just about everything else.
The U.S. municipal spend around fire in terms of your question, the comparative, I think will
continue to drag a little bit this year as weve said and you may see that in many other municipal
categories too. The good news for us even as it looks within the segment, the Fire & Safety
segment, is kind of the same story that we see prioritized spend for rescue tools globally more
than domestically, but even in the world of the domestic rescue tools spend, its also pretty
reasonable. So youve got to look at where the priorities for how the money is being spent. All up,
waters certainly in a very, very good position and looking very good looking forward and I dont
think fire gets any worse.
<Q Thomas Brinkmann>: Okay. Thats good color. Thank you. And also speaking of uses of
money, if you could just talk a little bit about broadly about how you make your decisions about
the uses of cash? Obviously the 25% hike in the quarterly dividend was nice. And how does that
compare with prioritization of say a special dividend or share repurchases in the context of your
plans to make additional acquisitions?
<A Larry Kingsley>: Yes. Were right now were definitely growth focused. Our primary
capital deployment is making acquisitions and were looking forward to a solid capital deployment
plan for the year and beyond. And weve got a number of things that are already teed up that look
good. Were always going to make the right decisions. Were going to make good acquisitions at good
prices, but by and large the focus is capital deployed to grow the business.
<Q Thomas Brinkmann>: Okay. Thats all I had. Thank you.
<A Larry Kingsley>: Youre welcome.
Operator: Our next question comes from Ned Borland with Hudson Securities. Please state your
question.
<Q Ned Borland>: Good morning. Two quick ones here. One, could you share with us the
magnitude of the large retail order for Dispensing?
<A Larry Kingsley>: For some market competitive reasons were not going to get into a lot
of detail. But I will give you some further, I guess, color again, here on what weve achieved.
Just let me step back a couple of steps.
So these infrastructure projects are going on all over the world. In many cases the water
infrastructure work has already been privatized. Thats the case in the U.K. And in the U.K. they
run a 5-year cycle. And there are 10 districts I think it is in the U.K. This order and what was
recognized was the first of 5 years. So we only recognized 20% or so of the commitment, obviously
gives us a good bit of comfort that were going to continue to see good growth for a while to come.
And I would expect that well see nice order volume out of the other water applications, globally.
It may not always be mobile to year in nature, but that will definitely be the case for the stuff
that is to follow-on from what weve seen here in the U.K.
<Q Ned Borland>: Okay. I was actually thinking about the order for Dispensing that was
going to ship in the first half of the year.
<A Larry Kingsley>: Oh, Im sorry. Im sorry. For Dispensing that order is a DIY, so its a
retailer, Im sorry, placing an order for essentially new equipment to go into stores in the U.S.
and that order books and ships in the first half of this year. And essentially the impact there is
youve got a Q1 order, which fully ships by the end of Q2 and as I said in the prepared remarks the
comparable was again, its always lumpy, but the equivalent last year was a big order that largely
impacted Q2/Q3 of 09. So that order books and ships the first half of this year.
<Q Ned Borland>: Okay. And just to get back to the water and infrastructure-related
projects, I guess the duration of most of the projects is multi-year. Are there would you ship
consistent volumes along the duration of the project? Or is there some sort of sweet spot along the
way that we should be thinking of from a margin perspective?
<A Larry Kingsley>: Not from a margin perspective. If anything, the margins increase as you
go into the later phases of these programs. There isnt a huge variability from start to finish
though.
<Q Ned Borland>: Okay, thank you.
<A Larry Kingsley>: Youre welcome.
Operator: Our next question comes from Scott Graham with Ladenburg Thalmann. Please state your
question.
<Q Scott Graham>: Hey, good morning. Nice quarter, guys.
<A Larry Kingsley>: Thanks, Scott.
<Q Scott Graham>: Hey, wanted to maybe get under a couple of numbers here, that Health &
Science number, which not only the sales number was terrific, but also the orders number. And maybe
to the extent that you are able to, Larry, split kind of order of magnitude; was this about the
same in core versus industrial? Was the industrial did the industrial get helped by an easy comp?
Because thats an extraordinary number. And I was just hoping you could kind of give us a feel for
the waiting of one versus the other.
<A Larry Kingsley>: The short answer, Scott, it was all good. And its not really so much
against the easy comp, frankly, as it is specific projects that OEM platforms won on both sides of
the house, also what we formerly talked about as core/non-core.
So we definitely have good evidence. We go through, as you well know, very detailed operating
reviews here. And very solid platform wins. Both on the analytical and the diagnostic side, but
also on the more industrially exposed portions of the business.
So Im very, very pleased with the teams execution in the quarter and for some of the stuff thats
to come here.
<Q Scott Graham>: Yeah, thats a very good number. The flip side is I do have a follow-up
question to an earlier question about that corporate expense, which I dont know if you mean on
dollars or on a percent of sales basis, Larry, that this is kind of maybe the new run rate. Either
way, however you slice that, it looks kind of high. And Im wondering if you can kind of get into a
couple things as to why.
<A Larry Kingsley>: Well, the short answer, Scott, is that some of what you have in the
quarter is management bonus, obviously. And thats a function of the team doing a great job through
the back half of 09. So on a both a dollar and a slice basis, you have that impact; as well as
in the quarter, there was fairly high legal expense number.
So you will see it improve. Dont assume that were spending our way frivolously out of this
recession.
<Q Scott Graham>: No. Not thinking that at all.
<A Larry Kingsley>: As well, there were some deal costs for our acquisition as well.
<Q Scott Graham>: I suspected that as well, yeah. Okay. Actually the last question, Fire &
Safety. And I guess specifically, Im not really concerned about Fire, because I think you kind of
have a good bead on what that is because of your relationships. But I think more interestingly is
how BAND-IT and Rescue Tools businesses are developing. And I know BAND-ITs a pretty high margin
business for you. Are you starting to see this because this seems to me to be a bit of an earlier
cycle, maybe an early indication, if youve got OEMs doing business with BAND-IT on a
solutions-driven platform basis; that seems to be a positive not only for BAND-IT, but also maybe
backing up into some of the fluid FMT business. Can you maybe talk about some of the things that
are happening at BAND-IT and maybe to the extent possible rescue tools as well?
<A Larry Kingsley>: Sure. BAND-IT is an earlier cycle business, theres no doubt about
that. However, with BAND-IT and I think we talked about this last quarter as well very solid
new products that have come out that were seeing nice incremental revenue out of. Some of it a
little bit faster than we had anticipated.
But what is really good news is again, back to the earlier question around how much of what were
seeing is a restocking contribution; weve dissected BAND-IT in extraordinary detail to understand
by channel member whats going on in terms of restocking Health versus sustained. And its not a
lot of restocking, frankly.
If you were to look at BAND-IT on a stand-alone organic basis, youd see something like 13% if
memory serves me correct. And we think a good chunk of that is new product revenue. Now are there -
is there a couple of points of contribution associated with the broadly based restocking? What
happens in both OEM and distribution channels? Perhaps. But its certainly not a bubble that we
think falls back off anytime soon.
As far as rescue, whats going on in Rescue is international wins. Were seeing and weve talked
about this pretty consistently right through the downturn. But now its even better. Were seeing
just outstanding national commitment to rescue tools from a number of the emerging markets. And not
the ones that are always so popularly discussed, but fairly small places around the world that care
a lot more about rescue.
If you were to look just at the domestic rescue numbers, itd be kind of blasé. But whats really
going to drive growth as I said is China, some of the other developing markets and disaster
recovery is top of mind right now. So slightly different elements to whats going on. But frankly,
all looking pretty good within the segment.
And then fire suppression, as I said earlier, we dont think that it gets any worse domestically.
Were kind of down to a minimum truck allocation, truck spend and type of truck, truck
appropriation.
So I think all up, the segment obviously continues to be really profitable, generates lots of cash,
benefits from the current mix, which is rescue and BAND-IT up and fire softer. So its certainly
not a drain in any fashion on the company. As you saw, we were up on margins a bit in the quarter.
<Q Scott Graham>: Got it. Thats all I had. Thanks a lot.
<A Larry Kingsley>: Thanks, Scott. Thanks.
Operator: [Operator Instructions] Our next question comes from Walt Liptak of Barrington Research.
<Q Walter Liptak>: Hi, thanks. Good morning, guys, and good quarter.
<A Larry Kingsley>: Thank you, Walt.
<Q Walter Liptak>: So I wanted to ask one more on the corporate expense, sorry about this.
But Im wondering if you could break out what management bonus was, incremental? How much legal
expense was incremental in the quarter?
<A Dominic Romeo>: Well, Walt, the accrual for bonuses right now as you know is an
estimate. So youll see that when the full year shapes out in the K. And legal expenses obviously
werent big enough for us to call out as a specific guide relative to earnings. They are obviously
- - wont be relative to run rate, but not relative to our performance in the quarter.
<Q Walter Liptak>: Okay. And then I guess without that number, wed have to do some
guessing. But so the corporate expense number for the full year, like in dollars?
<A Dominic Romeo>: Yeah. Were not going to guide at that level at this point. We gave you
the margin for the total company. So obviously you could model back towards the segment margin to
total.
<Q Walter Liptak>: Okay. All right. And with the orders in HST and FMT very nicely up, it
looks like youre being conservative on the back half revenue and margin. I wonder if you could
just address that observation and I guess I wonder about if you are being conservative, why are
there incremental costs or something in the back half that we should know about?
<A Larry Kingsley>: Its a fair statement, Walt. I think we obviously took our organic
assumptions up and we talked about some of the reasons why we see broader based positive
performance coming out the end markets and FMT and sustained very good growth in HST. You add those
2 segments up, thats just under three-quarters of the company in total. So you do have to get to
some pretty conservative assumptions in the back half.
At the same time, we took EPS up obviously a fair amount for the full year. Is it conceivable that
we continue at this pace through the full year broadly based, no drags anywhere, economy helps a
tad, a lot even frankly, but continues to be good and we go above the upper end of the range, its
possible. Yes. It is. And so are we perhaps being slightly conservative right now. I mean you can
argue that I suppose. We feel good, frankly, about execution so, I mean, irrespective of everything
else I think Im in good shape with respect to how I think the team is doing and I think well have
a good year.
<Q Walter Liptak>: Okay. Good. And then if I could switch to the fire and safety? You
mentioned domestic is down. The rest of the world is where youre getting the growth. I wonder if
you could give us numbers about like order trends. What were order trends in total for the quarter?
I might have missed that, the organic orders and how much is domestic down? How much is ROW [rest
of world] up?
<A Larry Kingsley>: Weve historically not really broken down organic orders sub segment,
but I think if you want we can give you that.
<A Dominic Romeo>: Walt, its probably an easier comp if you think about the sub segments.
So lets just call banded up up double digit plus. Fire in all up, down; 13, 15%. Then the rescue
side down slightly, but within that mix down double-digit kind of numbers in the U.S. and offset by
the foreign growth that Larry mentioned.
<Q Walter Liptak>: Okay. All right. Thanks. That helps.
<A Larry Kingsley>: Sure.
Operator: Our next question comes from Matt Summerville with KeyBanc. Please state your question.
<Q Matt Summerville>: Just a good morning. Question on FMT. You talked a little bit
geographically speaking about the water piece of the business. I was wondering if you could give a
little more detail into what youre seeing across the three major geographies in the non-water
pieces of FMT? And then I just want to make sure that Im comfortable with kind of your commentary
on the chemical side of the business. You guys were definitely, even just a quarter ago, much more
pessimistic on that piece of the business. And I guess what Im trying to get a feel for is what do
you think has happened to drive potential inflection point in the other in a positive direction
there?
<A Larry Kingsley>: Sure. Matt, well starting with water, as I said a minute ago, certainly
what were seeing is international projects translating to orders faster than domestic municipal
spend. All that said, were seeing some pretty good signs that domestic activity is now going to
bear some fruit here pretty shortly, too.
Energy you didnt ask about, but specifically energy is good globally. And for where we play and
where the reinvestment is going largely around distribution of fuels globally, pretty strong
activity. And also even in the areas such as LPG, as I think I mentioned in the prepared remarks.
But kind of a consistent story globally for what were seeing happen in energy. So if you take
water and energy and look at those growth rates for the segment, not terribly different than what
we thought about at the beginning of the year, but I would say incrementally were certainly seeing
better activity out of those alone.
And then as I said a minute ago with respect to lack of drag, the other big segment, the other big
end market for Fluid & Metering is chemical; and we didnt have very high hopes for chemical
globally for the year. Its getting better. And its a blend of projects that we can identify where
weve got product going into new lines and thats both in international applications as well as
U.S. But also with what were seeing in MRO [maintenance, repair, and operations] associated spend
and some of what we had going on last year was a bit of a double whammy where there werent any
chemical new capital programs and there even MRO spend was really tightened down. So I would say
low single-digit organic assumptions for chemical for us globally are pretty reasonable for the
full year.
As far as where we see lack of growth, anywhere if you want to call it that in FMT, continental
Europe is still flat. Where were seeing the strongest growth now versus our earlier end year
assumptions are a bit of a pick-up domestically. So yes, a bit different than what we had said a
quarter ago, but not radically different than our assumptions. And as we look forward I think the
good news is because its so broad based that I dont think FMT suffers any real drags for the full
year. Well continue to watch it and well have again a clearer view a quarter out but so far, so
good.
<Q Matt Summerville>: Thanks, Larry.
<A Larry Kingsley>: Sure.
Operator: I am not showing any other questions in the queue at this time. Id like to turn the
conference back over to the host.
Larry D. Kingsley, Chairman, President and Chief Executive Officer
Well, wed like to like to thank you for joining. As always, we appreciate your interest in the
company. Obviously the Q1 results were good and were really very well positioned to grow. No
concerns in terms of operational execution at this point. Were managing all very well. Were very
pleased to have the Seals team join IDEX. Welcome. Were going to put our balance sheet to work,
and we want to thank you. Well look forward to speaking to you through the quarter and at next
quarters call.
Operator: Thank you. Ladies and gentlemen, thank you for your participation in todays conference.
This does conclude the teleconference. You may now disconnect. Good day.